by Sue Robbins | Oct 14, 2013 | Headache Drugs
Speaking at the Congress of the European Pain Federation EFIC in Florence today, Professor Paolo Martelletti of Rome said of chronic migraine, “The disruptive nature of regular attacks can affect those around them and prove detrimental to many aspects of...
by Sue Robbins | Apr 23, 2013 | Headache Drugs
Plantar Fasciitis occurs when the band of tissue on the bottom of the foot is overused, causing inflammation. A new study has found that Botox, along with stretching eases plantar fasciitis pain better than steroids do. The FDA has not yet approved Botox for this...
by Dr Robbins | Jan 30, 2013 | Headache Drugs
Stephanie Watson, Executive Editor of Harvard Women’s Health Watch recently wrote an article describing her experiences as the daughter of a migraineur, as well as the “unseen” pain chronic migraine sufferers experience due to social stigma. The...
by Dr Robbins | Jan 23, 2013 | Headache Drugs
U.S. Specialty drugmaker Allergan has announced that it will buy MAP Pharmaceuticals, a purchase that will intensify Allergan’s presence in medicines for the treatment of adult migraines. Allergan manufactures Botox, which in the last few years has received...
by Dr Robbins | Jul 26, 2012 | Headache Drugs
A large study was recently presented at the 64th Annual Meeting of the American Academy of Neurology with findings indicating that headache-related nausea occurred in approximately 80% of people with migraines in the US population. According to Richard B.Lipton, MD,...
